Enveric Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Enveric Biosciences has a total shareholder equity of $5.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.1M and $645.3K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.50m |
| Equity | US$5.41m |
| Total liabilities | US$645.34k |
| Total assets | US$6.05m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SLZA's short term assets ($5.5M) exceed its short term liabilities ($645.3K).
Long Term Liabilities: SLZA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SLZA is debt free.
Reducing Debt: SLZA currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLZA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SLZA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.9% each year